Search

everythinglearnresearchcommunity

for

Search:↓

An AI photographic device effectively tracked hair growth improvements in women treated for hair loss.

Knee laxity varies with menstrual cycle phases, being highest during ovulation and menstruation, and is influenced by sex-steroids.

Changing neuroactive steroid levels early in life can affect how adult rats respond to alcohol's stimulating effects.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Ritlecitinib works well and is safe for treating alopecia areata.

PRP injections are safe and effective for alopecia areata, but steroids are still the preferred treatment.

The document corrects errors in previous articles, including a reversed term, updated subject weights, hair count data, and reference numbering.

Switching JAK inhibitors can lead to significant hair regrowth in severe alopecia cases.

Finasteride in lipid carriers improved hair growth in rats.

Patients were very satisfied with hair regrowth after taking ritlecitinib for alopecia areata.

Repaglinide-loaded liponiosomal hybrids improve blood sugar control and insulin release better than regular Repaglinide.

Young rats are better for testing hair loss treatments after chemotherapy.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Leflunomide and anthralin may effectively treat severe alopecia areata.

Most people with alopecia areata have nail changes, which are common but don't greatly affect their quality of life.

Rats with a pellagra-like skin condition were cured by a vitamin found in yeast, later identified as vitamin B6.

The document's conclusion cannot be provided because the content is not accessible.

Single-dose parenteral iron is safe and effective for children with inflammatory bowel disease and iron-deficiency anemia.

Baricitinib effectively treated alopecia areata in 73% of patients, with minor metabolic changes and significant changes in inflammatory markers.

Increased Toll-like receptors in blood cells may contribute to alopecia areata and could be a target for new treatments.

Liarozole may be more effective than cyproterone acetate for treating advanced prostate cancer, with better PSA response and survival rates, while maintaining quality of life.

New tools help assess eyebrow, eyelash, and nail changes in Alopecia Areata, improving understanding of patient experiences.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

A mutation in the IL2RA gene increases the risk of alopecia areata.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.